Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation

Journal of Immunology

Volumn 163, Issue 5, 1999, Pages 2944-2952

  Van Neerven, R J J ^a,c   Wikborg, T ^a   Lund, G ^a   Jacobsen, B ^a   Brinch Nielsen, A ^a   Arnved, J ^b   Ipsen, H ^a  

^a ALK ABELLÓ   (Denmark)

^b Lung and Allergy Clinic   (Denmark)

^c Tanox Pharma BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; POLLEN ANTIGEN;

ALLERGY; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINATION;

ALLERGENS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, BLOCKING; ANTIGEN PRESENTATION; ANTIGENS, CD19; BODY TEMPERATURE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DESENSITIZATION, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNE SERA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; PLANT PROTEINS; RECEPTORS, IGE; TREES;

EID: 0033197966     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. + T lymphocytes in atopic patients. J. Immunol. 144:4651.
2. Parronchi, P., D. Macchia, M. Piccinni, P. Biswas, C. Simonelli, E. Maggi, M. Ricci, A. A. Ansari, and S. Romagnani. 1991. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. USA 88:4538.
3. + allergen-specific T lymphocytes in atopic dermatitis lesional skin. J. Invest. Dermatol. 97:389.
4. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant Th2-like bronchoal veolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298.
5. Del Prete, G. F., M. De Carli, M. M. D'Elios, P. Maestrelli, M. Ricci, L. Fabbri, and S. Romagnani. 1993. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur. J. Immunol. 23:1445.
6. Bujankowski-Weber, J., B. Brings, I. Knoller, T. Pfeil, and W. Konig. 1989. Expression of low affinity receptor for IgE (FcεRII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors. Immunology 66:505.
7. Takigawa, M., T. Tamamori, D. Horiguchi, T. Sakamoto, M. Yamada, A. Yoshioka, K. Toda, S. Imamura, and J. Yodo. 1991. Fcε receptor II/CD23-positive lymphocytes in atopic dermatitis. I. The proportion of Fc expression of the a-subunit of the high affinity immunoglobulin E receptor(FcεRl-a). Clin. Exp. Allergy 26:648.
8. Maurer, D., E. Fiebiger, B. Reininger, B. Wolff-Winiski, M. H. Jouvin, O. Kilgus, J. P. Kinet, and G. Stingl. 1994. Espression of functional high affinity immunoglobulin E receptors (FcεRl) on monocytes of atopic individuals. J. Exp. Med. 179:745.
9. Tunon-de-Lara, J. M., A. E. Redington, P. Bradding, M. K. Church, J. A. Hartley, A. E. Semper, and S. T. Holgate. 1996. Dendritic cells in normal and asthmatic airways: expression of the a-subunit of the high affinity immunoglobulin E receptor (FcεRl-a). Clin. Exp. Allergy 26:648.
10. van der Heijden, F. L., R. J. J. van Neerven, M. van Katwijk, J. D. Bos, and M. L. Kapsenberg. 1993. Serum IgE-facilitated allergen presentation in allergic disease. J. Immunol. 150:3643.
11. Pirron, U., T. Schlunck, J. C. Prinz, and E. P. Rieber. 1990. IgE-dependem antigen focussing by human B lymphocytes is mediated by the low-affinity receptor for IgE. Eur. J. Immunol. 20:1547.
12. Kehry, M. R. and L. C. Yamashita. 1989. Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE dependent antigen focussing. Proc. Natl. Acad Sci. USA 86:7556.
13. Maurer, D., C. Ebner, B. Reininger, E. Fiebiger, D. Kraft, J. P. Kinet, and G. Stingl. 1995. The high affinity IgE receptor (FcεRl) mediates IgE-dependent allergen presentation. J. Immunol. 154:6285.
14. Mudde, G. C., F. C. van Reijsen, G. J. Boland, G. C. de Gast, P. L. B. Bruijnzeel, and C. A. F. M. Bruijnzeel-Koomen. 1990. Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE. Immunology 69:335.
15. Bousquet, J., R. F. Lockey, H. J. Malling, eds. 1998. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 53(Suppl.):1.
16. Noon, L. 1911. Prophylactic inoculation against hay fever. Lancet 1:1572.
17. Jacobsen, L., B. Nüchel Petersen, J. Å. Wihl, H. Løwenstein, and H. Ipsen. 1997. Immunotherapy with partially purified and standardized tree pollen extracts IV: results from long-term (6-year) follow-up. Allergy 52:914.
18. Walker, S. M., V A. Varney, M. Gaga, M. R. Jacobson, and S. R. Durham. 1995. Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study. Allergy 50:405.
19. Des Roches, A., L. Paradis, J. L. Menardo, S. Bouges, J. P. Daures, and J. Bousquet. 1997. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J. Allergy Clin. Immunol 99:450.
20. Jacobsen, L., S. Dreborg, H. A. Ferduosi, C. Møller, E. Valovirta, U. Wahn, B. Niggemann, S. Sparholt, and H. Løwenstein. 1998. Prevention of asthma by specific immunotherapy (the PAT study): five year follow up. Allergy 53(Suppl.43): 169 (Abstr.).
21. + T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ. J. Allergy Clin. Immunol. 97:1356.
22. Rak, S., A. Bjönson, L. Håkanson, S. Sörenson, and P. Venge. 1991. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J. Allergy Clin. Immunol. 88:878.
23. Witteman, A. M., S. O. Stapel, D. H. Sjamsoedin, H. M. Jansen, and R. C. Aalberse. 1996. Fel d 1-specific IgG antibodies induced by natural exposure have blocking activity in skin tests. Int. Arch. Allergy Immunol. 109:369.
24. Golden, D. B., D. A. Meyers, A. Kagey-Sobotka, M. D. Valentine, and L. M. Lichtenstein. 1982. Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy. J. Allergy Clin. Immunol. 69:489.
25. Jutel, M., U. R. Muller, M. Fricker, S. Rihs, W. J. Pichler, and C. Dahinden. 1996. Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils. Clin. Exp. Allergy 26:1112.
26. Lichtenstein, L., K. Ishizaka, P. Norman, A. Sobotka, and B. Hill. 1973. IgE antibody measurements in ragweed hay fever: relationship to clinical severity and the results of immunotherapy. J. Clin. Invest. 52:472.
27. Varney, V. A., Q. A. Hamid, M. Gaga, S. Ying, M. Jacobson, A. J. Frew, A. B. Kay, and S. R. Durham. 1993. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late phase cutaneous responses. J. Clin. Invest. 92:644.
28. Ebner, C., U. Siemann, B. Bohle, M. Willheim, U. Wiedermann, S. Schenk, F. Klotz, H. Ebner, D. Kraft, and O. Scheiner. 1997. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from Th2 to Th1 in T-cell clones specific for Ph1 p 1, a major grass pollen allergen. Clin. Exp. Allergy 27:1007.
29. Jutel, M., W. J. Pichler, D. Skrbic, A. Urwyler, C. Dahinden, and U. R. Muller. 1995. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen stimulated T cell cultures. J. Immunol. 154:4187.
30. + T cells from allergic individuals. J. Exp. Med. 178:2123.
31. Akdis, C. A, M. Akdis, T. Blesken, D. Wymann, S. S. Afkan, U. Muller, and K. Blaser. 1996. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. 98:1671.
32. Akdis, C. A., T. Blesken, M. Akdis, B. Wuthrich, and K. Blaser. 1998. Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 102:98.
33. + cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J. Allergy Clin. Immunol. 99:254.
34. Woodhead, J. S., and I. Weeks. 1989. Magic Lite design and development. J. Biolumin. Chemilumin. 4:611.
35. Ipsen, H., and O. C. Hansen. 1991. The NH2-terminal amino acid sequence of the immunochemically partial identical major allergens of alder (Alnus glutinosa) AIn g 1, birch (Betula verrucosa) Bet v 1, hornbeam (Carpinus betulus) Car b I and oak (Quercus alba) Que a 1 pollens. Mot. Immunol. 28:1279.
36. Ipsen, H., and H. Løwenstein. 1983. Isolation and immunochemical characterization of the major allergen of birch pollen (Betula verrucosa). J. Allergy Clin. Immunol. 72:150.
37. Sparholt, S. H., J. N. Larsen, H. Ipsen, C. Schou, and R. J. J. van Neerven. 1997. Cross-reactivity and T cell epitope-specificity of Bet v 1-specific T cells suggest the involvement of multiple isoallergens in the sensitization to birch pollen. Clin. exp. Allergy 27:932.
38. Heyman, B., L. Tianmin, and S. Gustavsson. 1993. In vivo enhancement of the specific antibody response via the low-affinity receptor for IgE. Eur. J. Immunol. 23:1739.
39. Oshiba, A., E. Hamelmann, A. Haczku, K. Takeda, D. H. Conrad, H. Kikutani, and E. W. Gelfand. 1997. Modulation of antigen-induced B and T cell responses by antigen-specific IgE antibodies. J. Immunol. 159:4056.
40. Squire, C. M., E. J. Studer, A. Lees, F. D. Finkelman, and D. H. Conrad. 1994. Antigen presentation is enhanced by targeting antigen to the FcεRII by antigen-anti-FcεRII conjugates. J. Immunol. 152:4388.
41. Fujiwara, H., H. Kikutani, S. Suematsu, T. Naka, K. Yoshida, T. Tanaka, M. Suemura, N. Matsumoto, S. Kojima, et al. 1994. The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc. Natl. Acad. Sci. USA 91:6835.
42. Fahy, J. V., H. E. Fleming, H. H. Wong, J. T. Liu, J. Q. Su, J. Reimann, R. B. Fick, and H. A. Boushey. 1997. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am. J. Respir. Crit. Care Med. 155:1828.
43. Hamelmann, E., A. Oshiba, J. Schwarze, K. Bradley, J. Loader, G. L. Larsen, and E. W. Gelfand. 1997. Allergen-specific IgE and IL-5 are essential for the development of airway hyper-responsiveness. Am. J. Resp. Cell. Mol. Biol. 16:674.
44. Oshiba, A., E. Hamelmann, K. Takeda, K. L. Bradley, J. Loader, G. Larsen, and E. W. Gelfand. 1996. Passive transfer of immediate hypersensitivity and airway hyper-responsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J. Clin. Invest. 97:1398.
45. Coyle, A. J., K. Wagner, C. Bertrand, S. Tsuyuki, J. Bews, and C. Heusser. 1996. Central role of immunoglobulin-E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J. Exp. Med. 183:1303.
46. Durham, S. R., H. J. Gould, C. P. Thienes, M. R. Jacobson, K. Masuyama, S. Rak, O. Lowhagen, E. Schotman, L. Cameron, and Q. A. Hamid. 1997. Expression of ε germ-line gene transcripts and mRNA for the ε heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur. J. Immunol. 27: 2899.
47. Minskoff, S. A., K. Matter, and I. Mellman. 1998. FcγRII-BI regulates the presentation of B cell receptor-bound antigens. J. Immunol. 161:2079.
48. Tsuyuki, S., J. Tsuyuki, K. Einsle, M. Kopf, and A. J. Coyle. 1997. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J. Exp. Med. 185: 1671.
49. Krinzman, S. J., G. T. Desanctis, M. Cernadas, D. Mark, Y. S. Wang, J. Listman, L. Kobzik, C. Donovan, K. Nassr, I. Katona, D. C. Christiani, D. L. Perkins, and P. W. Finn. 1996. Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. J. Clin. Invest. 98:2693.
50. + T lymphocytes, activated eosinophils and the magnitude of the allergen-induced late phase skin reaction in man. J. Immunol. 141:4158.
51. Corrigan, C. J., and A. B. Kay. 1992. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13:501.
52. Harris, N., R. Peach, J. Naemura, P. S. Linsley, G. Legros, and F. Ronchese. 1997. CD80 costimulation is essential for the induction of airway eosinophilia. J. Exp. Med. 185:177.
53. Barata, L. T., S. Ying, Q. Meng, J. Barkans, K. Rajakulasingam, S. R. Durham, and A. B. Kay. 1998. IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Allergy Clin. Immunol. 101:222.
54. Keatings, V. M., B. J. Oconnor, L. G. Wright, D. P. Huston, C. J. Corrigan, and P. J. Barnes. 1997. Late response to allergen is associated with increased concentrations of tumor necrosis factor-α and IL-5 in induced sputum. J. Allergy Clin. Immunol. 99:693.
55. Bousquet, J., and F. Michel. 1992. Immunotherapy in rhinitis. In Allergic and Non-Allergic Rhinitis: Clinical Aspects. N. Mygind and R. Naclerio, eds. Munksgaard, Copenhagen, 136-148.
56. Wierenga, E. A., M. Snoek, J. D. Bos, H. M. Jansen, and M. L. Kapsenberg. 1990. Comparison of diversity and function of house dust mite-specific T lymphocyte clones from atopic and non-atopic donors. Eur. J. Immunol. 20:1519.
57. Jeannin, P., S. Lecoanet, Y. Delneste, J. Gauchat, and J. Y. Bonnefoy. 1998. IgE versus IgG4 production can be differentially regulated by IL-10. J. Immunol. 160:3555.
58. Yamashita, N., M. Takeno, S. Kaneko, Y. Mizushima, and T. Sakane. 1997. Therapeutic effects of åreferential induction of mite-specific T helper 0 clones. Clin. Exp. Immunol. 109:332.
59. Vrtala, S., T. Ball, S. Spitzauer, B. Pandjaitan, C. Suphioglu, B. Knox, W. R. Sperr, P. Valent, D. Kraft, and R. Valenta. 1998. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation. J. Immunol. 160:6137.
60. Bonnefoy, J. Y., C. Plater-Zyberk, S. Lecoanet-Henchoz, J. F. Gauchat, J. P. Aubry, and P. Graber. 1996. A new role for CD23 in inflammation. Immunol. Today 17:418.